Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.
Increasing the injection volume had no significant long-term effect on the distribution or tissue dose of intraperitoneal 32P in New Zealand white rabbits. Further, the range of doses and dose rates observed in the rabbit had little effect in vitro against either a human ovarian cancer line or an established Chinese hamster cell line. Demonstrable kill of human ovarian cancer cells was achieved, however, for initial 32P dose rates of 11 and 22 rad/h (0.11 and 0.22 Gy/h). From these results, it is estimated that administered 32P activities ranging from about 75-150 mCi (2.8-5.6 GBq) would be required for significant tumoricidal effects in ovarian cancer patients.
D000818:Animals; D001345:Autoradiography; D002277:Carcinoma / Q000532:radiotherapy; D002460:Cell Line / Q000528:radiation effects; D002857:Chromium / Q000008:administration & dosage; D017608:Chromium Compounds; D006224:Cricetinae; D003964:Diaphragm / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D005260:Female; D007274:Injections, Intraperitoneal; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D010710:Phosphates / Q000008:administration & dosage; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage*; D011879:Radiotherapy Dosage; D051381:Rats
D017608:Chromium Compounds; D010710:Phosphates; D010761:Phosphorus Radioisotopes; D002857:Chromium; C509369:chromic phosphate